Industry

Pharmapack 2025, one of the most anticipated events in the pharmaceutical and healthcare industries, is set to take place in Paris, France. Scheduled for this month, this global gathering will bring together key players from pharmaceutical packaging, medication delivery, medical devices, and machinery sectors. The event promises to spotlight cutting-edge innovations and foster meaningful collaborations […]

When you think about the NFL Draft, images of scouts, strategy, and high-stakes decisions come to mind. Big Pharma, on the other hand, conjures up thoughts of clinical trials, research breakthroughs, and regulatory hurdles. At first glance, these two industries might seem worlds apart. However, for investors, the parallels between the NFL Draft and Big

The high cost of insulin has been a significant concern in the United States for years. Millions of people depend on this life-saving medication, yet its price continues to rise, putting a heavy financial burden on patients with diabetes. Recently, the Federal Trade Commission (FTC) took action, filing a lawsuit against prescription middlemen, accusing them

Recent data from a new ASHP (American Society of Health-System Pharmacists) report reveals an intriguing trend in prescription medication spending across the United States. While the overall national expenditure experienced a significant surge, increasing by 13.5% from 2022 to 2023 and totaling a staggering $722.5 billion, this growth was not mirrored in hospital pharmacy spending.

In a significant legal development, the 5th Circuit Court partially affirmed a ruling that deemed the Preventive Services Task Force unconstitutional. This task force is responsible for determining the coverage of certain preventive services under the Affordable Care Act (ACA). Additionally, the appellate court upheld the grant of injunctive relief for the plaintiffs in the

April 2nd marks a significant step in the ongoing battle against medication shortages as the U.S. Department of Health and Human Services (HHS) releases a comprehensive white paper addressing the issue head-on. Medication shortages have plagued the nation’s healthcare system for decades, primarily due to market failures and misaligned incentives. With the release of this

Observed annually around March 10th to March 16th, Patient Safety Awareness Week serves as a reminder of the critical importance of safety in healthcare. At Atlantic Biologicals, this week holds special significance as we reaffirm our commitment to quality and safety in pharmaceutical distribution. Patient Safety Awareness Week aims to foster crucial conversations and catalyze

The pharmaceutical distribution landscape faces challenges in the wake of dramatic margin fluctuations and financial struggles within the hospital sector. As we enter 2024, Atlantic Biologicals, emerges as a steadfast partner, navigating the complex terrain of the healthcare industry. Understanding the Pharmaceutical Distribution Landscape 2022 marked one of the worst financial years for hospitals in